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Abstract—Rosacea is a chronic inflammatory condition that predominantly affects the skin of the face.
Sera from rosacea patients display elevated reactivity to proteins from a bacterium (Bacillus oleronius)
originally isolated from aDemodexmite from a rosacea patient suggesting a possible role for bacteria in
the induction and persistence of this condition. This work investigated the ability of B. oleronius proteins
to activate neutrophils and demonstrated activation via the IP3 pathway. Activated neutrophils displayed
increased levels of IP1 production, F-actin formation, chemotaxis, and production of the pro-
inflammatory cytokines IL-1β and IL-6 following stimulation by pure and crude B. oleronius protein
preparations (2 μg/ml), respectively. In addition, neutrophils exposed to pure and crude B. oleronius
proteins (2 μg/ml) demonstrated increased release of internally stored calcium (Ca2+), a hallmark of the
IP3 pathway of neutrophil activation. Neutrophils play a significant role in the inflammation associated
with rosacea, and this work demonstrates how B. oleronius proteins can induce neutrophil recruitment
and activation.
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INTRODUCTION
Rosacea is a chronic inflammatory dermatosis that
affects the skin of the face, the eyelid margins, and the
corneal surface [1–3]. A number of forms of rosacea have
been recognized and include papulopustular, ocular,
phymatous, and erythematotelangiectatic [4, 5]. While the
etiology of rosacea is complex andmay involve a variety of
factors, treatment of the condition has relied upon the use
of antibiotics (e.g., metronidazole and tetracycline)
[6–8], and therapy is characterized by periods of
remission and relapse [3]. The efficacy of antibiotics
in controlling the condition may be due to their anti-
inflammatory properties, although anti-inflammatory
agents such as steroids and tacrolimus are not effec-
tive in treating the condition and their use can lead
to deterioration of the condition [6].
Neutrophils play a central role in the innate immune
response against pathogens, and a role in the inflammation
which is characteristics of rosacea has been suggested [9].
Many agents used in the treatment of rosacea, such as
tetracyclines, azelaic acid, retinoids, and metronidazole
[9–11], inhibit reactive oxygen species (ROS) production
by neutrophils and lead to clearance of the condition.
Neutrophils may also induce tissue damage by the release
of proteolytic enzymes during degranulation which can
degrade collagen [12, 13] and activate key signaling path-
ways [14, 15] which can result in inflammation.
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The regulation of intracellular neutrophil signal trans-
duction for chemotaxis and degranulation requires an in-
crease in the cytosolic Ca2+ [16]. Chemoattractant
signaling molecules such as fMLP or IL-8 bind to a G-
protein-coupled receptor (GPCR) leading to the activation
of the β isoform of phospholipase C (PLC), and the gen-
eration of the second messenger, inositol 1,4,5-triphos-
phate (IP3). This results in the rapid release of stored
Ca2+ from Ca2+-gated ion channels of calciosomes, and
neutrophil activation [17]. The signaling cascade for the
release of internally stored Ca2+ following the generation
of IP3 has been proposed as a potential therapeutic target
against the inflammatory response of neutrophils in a range
of diseases [16, 18, 19].
Rosacea patients demonstrate an elevated density
of Demodex mites in their skin compared to controls
[20–22]. The nature of the sebum produced on the
faces of rosacea patients is different to that in controls
[23], and this may facilitate the growth in the Demodex
population. It has been suggested that the elevated
density of Demodex mites may irritate the lining of
the pilosebaceous unit and initiate an inflammatory
response [3].
A number of studies have suggested that bacteria
may play a role in the induction of rosacea [24–26]. A
bacterium (Bacillus oleronius) was isolated from a
microdissected Demodex mite extracted from the face
of a papulopustular rosacea patient [25], and this bac-
terium was previously isolated from the digestive tract
of a termite where it may facilitate digestion [27]. This
bacterium has also been isolated from Demodex mites
and eyelashes of patients with blepharitis [28] and is
sensitive to the antibiotics used to treat rosacea [25].
Sera from patients suffering from papulopustular [25],
ocular [29], and erythematotelangiectatic [30] rosacea
demonstrated elevated reactivity to proteins isolated
from B. oleronius, thus suggesting a possible link
between the presence of this bacterium and rosacea
[2, 3, 25]. A positive correlation between serum reac-
tivity to Bacillus protein, elevated Demodex density,
and altered sebum production has been established
[31]. It has previously been demonstrated that exposure
of a corneal epithelial cell line to Bacillus proteins
induced cell migration and an aberrant wound healing
response [32]. The Bcrude^ B. oleronius protein prep-
aration [32, 33] used here consists of all the B. oleronius
proteins that might be released from dead Demodex while
the Bpure^ protein preparation consists of the B. oleronius
proteins to which rosacea patients show serum reactivity
[25, 29, 30].
Exposure of neutrophils to proteins from B. oleronius
resulted in degranulation and the production of inflamma-
tory cytokines [34]. The aim of the work presented in this
study was to characterize the response of neutrophils to
Bacillus proteins as this may explain how the release of
these proteins from Demodex mites in the pilosebaceous
unit could lead to neutrophil activation and inflammation.
MATERIALS AND METHODS
Preparation of Bacterial Protein Preparations
B. oleronius cells were incubated at 30 °C and
200 rpm in nutrient broth (Oxoid) under aerobic conditions
to the stationary phase, and proteins were extracted and
purified as described [25]. The protein preparation was
purified by anion exchange separation by ÄKTA-FPLC
as described [33]. Fractions corresponding to the proteins
of interest were pooled, precipitated (termed pure
B. oleronius protein) and resuspended in phosphate-
buffered saline (PBS) at a concentration of 200 μg/ml.
Based on previous studies investigating the effects of the
B. oleronius protein preparations, two doses (2 and
6 μg/ml) of the crude and pure protein preparations were
employed here [25, 33, 34].
Isolation of Neutrophils
Human neutrophils were isolated from healthy volun-
teers by dextran (10 %, w/v; Sigma) sedimentation and
Ficoll-Hypaque centrifugation (Axis-Shield PoC AS,
Oslo, Norway) as described [35]. Cell viability was
assessed by the trypan blue exclusion assay [36]. Ethical
approval for the isolation of human neutrophils was
granted by NUIM ethics committee.
Quantification of D-myo-Inositol-1-Phosphate
The quantity of IP1 in neutrophils was assessed using
an IP-One ELISA assay kit (Cisbio Bioassays, Codolet,
France). Freshly isolated human neutrophils (5×106/ml)
were re-suspended in stimulation buffer, and stimulants
were added (N-formyl-methionyl-leucyl-phenaylalnine
(fMLP; positive control), 1 μM; interleukin (IL)-8 (posi-
tive control), 10 ng/ml (positive control); crude
B. oleronius protein, 2 and 6 μg/ml; and pure
B. oleronius protein, 2 and 6 μg/ml) at 37 °C in a 5 %
CO2 humidified atmosphere for 1 h. After development,
the ELISA plate was read at absorbance 450 nm on a
BioTek Synergy™HT (BioTek Instruments Inc., Vermont,
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USA) microplate reader to generate a standard curve and
quantify levels of IP1.
Quantification of Intracellular Ca2+ Flux in Neutrophils
Intracellular calcium (Ca2+) levels of neutrophils
exposed to IL-8 (10 ng/ml), fMLP (1 μM), crude
B. oleronius protein (2 μg/ml), pure B. oleronius protein
(2 μg/ml), and unstimulated neutrophils were measured
using the Fluo-4 NW calcium assay kit (Molecular
Probes®, Invitrogen™ Detection Technologies). Ca2+
fluorescence was determined with excitation/emission at
494/516 nm, and read at 10-s intervals for a total of 90 s
with stimulation of human neutrophils occurring after 40 s,
indicated by a downward arrow, using a microplate reader.
F-Actin Polymerization Following Exposure
of Neutrophils to Bacillus Proteins
F-actin and G-actin abundance and distribution were
assessed according to the method described by [37]. Neu-
trophils were isolated and resuspended at a density of
1×107 cells per treatment and stimulated with IL-8
(10 ng/ml), crude B. oleronius protein (2 and 6 μg/ml), or
pure B. oleronius protein (2 and 6 μg/ml), at 37 °C for
10 min.
Equal volumes of extracted sub-cellular neutrophil
fractions were loaded onto a 12.5 % SDS-PAGE gel and
separated under reducing conditions, resolved by electro-
phoresis, transferred onto a nitrocellulose membrane
(Thermo Scientific™, Fisher Scientific Ltd., Ireland), and
probed for G- and F-actin abundance (Anti-Actin, Clone
C4, Millipore, Germany), followed by an anti-human
HRP-linked secondary antibody (HRP-linked mouse anti-
serum). Immunoreactive protein bands were visualized by
incubating the membranes for 10 min in diaminobenzidine
tetrahydrochloride [DAB; 1 mg/l in 100 mM Tris–HCl
(pH 7.6) containing 15 μl of hydrogen peroxide] before
washing in distilled water and drying. Immunobands were
quantified by densitometry using ImageJ software (NIH,
MD, USA).
Measurement of Neutrophil Chemotaxis
Chemotaxis assays were performed using a multi-
well chemotaxis chamber (Neuro Probe, Inc., MD, USA),
and a 5 μM pore filter (Neuro Probe) with the stimulants
(fMLP, 1 μM; IL-8, 10 ng/ml; crude B. oleronius protein,
2 μg/ml; pure B. oleronius protein, 2 μg/ml) added to the
bottom of the chamber. Cells that had completely migrated
through the filter were counted in five random high-power
fields of vision (Magnification 40×) per well per treatment
by light microscopy.
Pro-inflammatory Cytokine Enzyme-Linked Immuno-
sorbent Assay (ELISA)
Isolated human neutrophils (1×106/ml in RPMI-1640
GlutaMAX™ media (Gibco®) supplemented with 5 % (v/
v) FCS) were added to each well of a 24-well flat-bottomed
tissue culture plate (Falcon™, BD Biosciences, UK) and
incubated for 16 and 24 h. Cells were treated with 2 and
6 μg/ml of the crude B. oleronius protein and pure
B. oleronius protein, and IL-8 (10 ng/ml). Cell culture
supernatants were harvested and the levels of IL-1β and
IL-6 were measured using commercial ELISA kits
(Mabtech Ab) according to the manufacturer’s guidelines.
The plates were read at 405 nm for the IL-1β ELISA, and
at 450 nm for the IL-6 ELISA on a microplate reader.
Statistical Methods
The statistical significance was assessed using Prism5
software (GraphPad Software, San Diego, CA, USA). Data
are presented as the mean±standard error. Statistical anal-
ysis was performed by paired Student’s t test. A p value
less than 0.05 was deemed statistically significant.
RESULTS
Exposure of Neutrophils to Bacillus Proteins Leads
to Increased D-myo-Inositol 1-Phosphate (IP1) Levels
The quantification of IP1 in neutrophils was per-
formed as described as this can be used as a measure of
IP3, a second messenger involved in neutrophil signaling
[17]. An increase in IP1 production was observed follow-
ing exposure of neutrophils to the pure B. oleronius protein
preparation at 2 μg/ml (4.7-fold, p=0.016) and 6 μg/ml
(4.4-fold, p=0.02; Fig. 1). Exposure of neutrophils to the
crude B. oleronius protein extract led to an increase of IP1
in 2 μg/ml (13.9-fold; p=0.011) and 6 μg/ml (10.9-fold;
p=0.032) treatments, and these values were similar to IP1
levels detected for neutrophils stimulated with fMLP
(1 μM; 13.8-fold; p=0.0146) and IL-8 (10 ng/ml;
8.5-fold; p=0.0046; Fig. 1).
Calcium Efflux in Neutrophils Exposed to Bacillus
Protein
The activation of neutrophils is characterized by the
rapid movement of intracellular Ca2+ ions stored in the
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calciosomes induced by IP3 receptor binding [38–41].
Stimulation of neutrophils with B. oleronius protein
preparations resulted in a rise in released Ca2+ (Fig. 2).
The increase in Ca2+ levels was significant following
exposure of neutrophils to the crude B. oleronius protein
preparation (2 μg/ml; 1.4-fold; p=0.030) at 10 s. At 40 s
post-stimulation, Ca2+ flux was increased in neutrophils
exposed to crude B. oleronius protein (1.5-fold; p=0.021),
pure B. oleronius protein (1.3-fold; p=0.003), and IL-8
(1.3-fold; p=0.003). Stimulation of neutrophils with fMLP
(1 μM) resulted in an increase in Ca2+ levels at 10 (1.1-
fold), 20 (1.2-fold), 30 (1.2-fold), and 40 (1.2-fold)
seconds post-stimulation but was not statistically
significant.
Cytoskeletal Reassembly in Neutrophils Induced
by Bacillus Proteins
The ability of activated neutrophils to perform the
morphological and functional changes required to phago-
cytose and kill an opsonized pathogen is dependent upon
the conversion of G- to F-actin [42]. Neutrophils were
exposed to Bacillus protein extracts for 10 min, and the
relative abundance of G-actin and F-actin was quantified
by Western blot (Fig. 3a), and the distribution ratio was
calculated (Fig. 3b, C). In unstimulated neutrophils, the
abundance of G-actin exceeded that of F-actin by 2.6-fold.
Stimulation of cells with IL-8 (10 ng/ml) led to an increase
in F-actin (1.7-fold; p=0.025) and a relative decline in G-
actin (0.7-fold; p=0.028), demonstrating the cytoskeletal
conversion of G-actin to F-actin. Neutrophils exposed to
pure B. oleronius protein preparation (2 and 6 μg/ml)
showed significantly elevated levels of F-actin (2.0-fold,
p=0.011, and 1.5-fold, p=0.024, respectively) and reduced
abundance of G-actin (0.6-fold, p=0.048, and 0.8-fold,
p=0.025, respectively). The increase in F-actin following
exposure of neutrophils to pure B. oleronius protein
at 6 μg/ml was calculated to be significant compared
to pure B. oleronius protein at 2 μg/ml (p=0.019),
Fig. 1. Effect of B.oleronius protein preparation on IP1 formation in neutrophils. Neutrophils were exposed to PBS (unstimulated), fMLP (1 μM), IL-8
(10 ng/ml), pure B. oleronius protein (2 and 6 μg/ml), and crude B. oleronius protein (2 and 6 μg/ml) for 10 min, and the effect on IP1 formation in cytosols
was quantified. Significance: *p<0.05, **p<0.01.
Fig. 2. Effect of B. oleronius protein preparation on calcium flux in neu-
trophils. Isolated neutrophils were exposed to PBS (unstimulated), IL-8
(10 ng/ml), fMLP (1 μM), crude B. oleronius protein extract (2 μg/ml), or
pure B. oleronius protein extract (2 μg/ml), and the effect on cytosolic
Ca2+ flux was measured. Stimulation of neutrophils by the different
treatments occurred at 0 s (indicated by arrow). Significance: *p<0.05,
**p<0.01. (Figure is a representative of one repeat of the assay performed
in triplicate, and the statistics are representative of the assay performed in
triplicate relative to the unstimulated control.)
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and crude B. oleronius protein at 6 μg/ml (p=0.008).
The relative levels of F-actin were increased in neu-
trophils exposed to the crude B. oleronius protein
preparation with a significant increase of F-actin,
1.4-fold, at 2 μg/ml (p=0.04). Exposure of neutro-
phils to crude B. oleronius protein at 6 μg/ml in-
duced a 1.7-fold increase in F-actin but did not reach
significance (p=0.0557). The abundance G-actin de-
clined significantly following exposure of neutrophils
to crude B. oleronius protein preparation at 2 and
6 μg/ml (0.7-fold, p=0.0165, and 0.7-fold, p=0.0147,
respectively; Fig. 3c).
Induction of Neutrophil Chemotaxis in Response
to Bacillus Proteins
The effect of B. oleronius crude (2 μg/ml) and
pure protein (2 μg/ml) preparations on neutrophil
chemotaxis was investigated. The results demonstrat-
ed that exposure to IL-8 (10 ng/ml) led to a 2.9-fold
(p<0.0001) increase in neutrophil chemotaxis. Expo-
sure to the crude B. oleronius protein preparation or
to the pure B. oleronius protein preparation induced a
3.5-fold (p<0.0001) or 3.9-fold (p<0.0001) increase
in migration of neutrophils toward a chemotactic
gradient, respectively (Fig. 4).
Exposure of Neutrophils to Bacillus Proteins Leads
to Elevated IL-1β and IL-6 Secretion
The effect of B. oleronius protein preparations on the
ability of neutrophils to secrete IL-1β and IL-6 was inves-
tigated. IL-1β is a pro-inflammatory cytokine and also
functions in cell proliferation and the induction of apopto-
sis [43]. IL-6 is a pro-inflammatory cytokine associated
with the response to bacterial infection, and high levels of
expression have been recorded in psoriatic skin [44].
Neutrophils exposed to pure B. oleronius protein (2
and 6 μg/ml) demonstrated significant increases in IL-1β
production after 16 (201 and 150 pg/ml, respectively) and
24 (89 and 83 pg/ml, respectively) hours of incubation
(p<0.0001; Fig. 5a). There was a significant increase in
IL-1β secretion by neutrophils exposed to pure
B. oleronius protein at 2 μg/ml (p=0.0005), and at
6 μg/ml (p=0.0003) after 16 h, and after 24-h exposure
at 2 μg/ml (p=0.0009) and at 6 μg/ml (p<0.0001) pure
B. oleronius protein. In contrast, cells exposed to the
crude B. oleronius protein preparation (2 and 6 μg/ml)
showed no alteration in IL-1β secretion (Fig. 5a).
Neutrophils exposed to 2 or 6 μg/ml pure or crude
B. oleronius protein preparation demonstrated increased
secretion of IL-6 production (p<0.001) with the highest
amount occurring at 24 h (Fig. 5b). IL-6 production
G-Actin
F-Actin
ba
c
Distribution Ratio
G-actin : F-actin
Unstimulated 2.6 : 1.0
IL-8 (10 ng/ml) 1.7 : 1.9
Crude (2 µg/ml) 1.7 : 1.9
Pure (2 µg/ml) 1.6 : 2.0
Crude (6 µg/ml) 1.5 : 2.0
Pure (6 µg/ml) 1.5 : 2.0
Fig. 3. Alteration inG/F-actin ratio in neutrophils exposed toB. oleronius protein preparations. The abundances of G-actin and F-actin were assessed for each
treatment by Western blot (a), the distribution ratio of G-actin/F-actin was calculated (b), and the abundance of G-actin and F-actin for each treatment was
quantified using ImageJ densitometric software (c). Significance: *p<0.05.
429Bacillus Proteins and Neutrophil Activation
increased 2.5-fold and 2.2-fold following exposure of neu-
trophils to 2 and 6 μg/ml pure B. oleronius protein
(p<0.0001, and p=0.0048, respectively) after 16 h. Treat-
ment of neutrophils with the crude B. oleronius protein
preparation at 2 and 6 μg/ml produced similar levels of IL-
6 compared to IL-6 production following stimulation by
IL-8. After 24 h, IL-6 production increased 1.8-fold and
1.9-fold following exposure of neutrophils to pure
Fig. 4. Effect of B. oleronius protein preparations on neutrophil chemotaxis. Neutrophils were isolated and exposed fMLP (1 μM), IL-8 (10 ng/ml), pure
B. oleronius protein (2 μg/ml), and crude B. oleronius protein (2 μg/ml) for 30 min, and the effect on neutrophil migration along a chemotactic gradient was
quantified. Significance: ***p<0.001.
ba
Fig. 5. Production of IL-1β and IL-6 by neutrophils exposed to B. oleronius protein preparations. Neutrophils were exposed to IL-8 (10 ng/ml), pure
B. oleronius protein (2 and 6 μg/ml), or crude B. oleronius protein preparation (2 and 6 μg/ml), for 16 and 24 h. The secretion of the pro-inflammatory
cytokines, IL-1β (a) and IL-6 (b), was measured by ELISA. Significance: *p<0.05, **p<0.01, ***p<0.001.
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B. oleronius protein (p=0.0001, and p=0.0018, respective-
ly). Exposure of neutrophils to crude B. oleronius protein at
2 and 6 μg/ml showed similar levels of IL-6 compared to
the production of IL-6 following stimulation by IL-8 (pos-
itive control).
DISCUSSION
The role of Demodex mites in the biology of the skin
has been intensely studied by dermatologists and scientists
since their discovery by Henle and Berger (1841) [45].
Akilov and Mumcuoglu [46] showed that individuals with
the HLA Cw2 and Cw4 haplotypes were more susceptible
to increased Demodexmite infestation in the skin and have
a decreased natural killer T cell population. Casas et al.
[47] quantified D. folliculorum mite colonization in
erythematotelangiectatic rosacea and papulopustular rosa-
cea patients and investigated the activation of a skin innate
immune response. They demonstrated that genes coding
for IL-8, IL-1β, TNF-α, and Cox-1 were increased, and
observed elevated expression of genes coding for the
inflammasome.
Features of the skin microenvironment including tem-
perature, pH, and sebum composition could influence
Demodex mite population development and thus the onset
of symptoms associated with rosacea [2, 23, 48–50]. Mu-
rillo and colleagues [51] characterized the microbiota of
Demodex mites isolated from rosacea patients and identi-
fied a wide range of bacteria in the mites. Studies have
demonstrated high levels of rosacea patient sera reactivity
to proteins produced by B. oleronius, a bacterium isolated
from a Demodex mite from a patient with papulopustular
rosacea, indicating a possible role for this or closely related
bacteria in the induction of rosacea [25, 29–31]. Neutrophil
influx and activation are considered a key factor in the
induction of inflammation in the skin of rosacea patients
[6, 8]. We have previously demonstrated that neutrophils
exposed to B. oleronius proteins showed increased migra-
tion and elevated release of MMP-9 and cathelicidin [34].
This may contribute to the tissue damage and inflammation
evident in areas of skin characteristic of rosacea. In the
current work, the process which results in neutrophil acti-
vation has been characterized.
Analysis of the B. oleronius protein preparations used
here confirmed the absence of LPS contamination (see
supplementary file, Figs. S1, S2, and S3), thus indicating
that effects observed here were not attributable to endotox-
in presence. Neutrophils exposed to the B. oleronius pro-
tein preparations demonstrated elevated levels of IP1
indicating the activation of GPCR signaling leading to
the generation of the secondary messenger IP3 [17]
(Fig. 1). Neutrophils activated through the IP3 pathway
exhibit a rapid release of internally stored Ca2+ following
the occupancy of IP3 and its receptors on the Ca
2+-gated
ion channels of the calciosomes, with a return to the basal
level of cystolic Ca2+ by the action plasma membrane and
sacro(endo)plasmic reticulum Ca2+-ATPase (SERCA)
pumps [16, 17, 52–54]. The results presented here indicate
that exposure of neutrophils to B. oleronius protein prepa-
rations leads to a rapid release of stored Ca2+ which begins
to decline 50 s after the application of the proteins (Fig. 2).
Following stimulation of neutrophils by the B. oleronius
proteins, activated neutrophils also demonstrated elevated
levels of F-actin (Fig. 3), increased chemotaxis, indicating
movement toward the Bacillus proteins (Fig. 4), and in-
creased production of the pro-inflammatory cytokines, IL-
1β and IL-6 (Fig. 5a, b).
One scenario that might explain the follicular-
orientated inflammation characteristic of papulopustular
rosacea suggests the release of antigenic bacterial proteins
from dead Demodex mites within the pilosebaceous unit.
These are released from the pilosebaceous unit, attracting
neutrophils to the surrounding area. Activated neutrophils
degranulate, releasing MMP-9 and cathelicidin which
cause tissue damage. Neutrophils also produce elevated
levels of IL-8 and TNF-α attracting more neutrophils to
the vicinity and induce an exaggerated inflammatory re-
sponse [34]. The current work demonstrates that exposure
of neutrophils to the Bacillus proteins induces chemotaxis
and the activation of neutrophils via the IP3 pathway.
Activated neutrophils release elevated level of IL-6 and
IL-1β which play a central role in inducing an inflamma-
tory reaction in dermal tissue [43, 44]. The secretion of IL-
1β and TNF-α is associated with the expression of NF-κB
[55]. Azelaic acid, a therapy for the treatment of rosacea,
has been shown to modulate the inflammatory response by
suppressing IL-1β, TNF-α, and IL-6 secretion in normal
human keratinocytes by activation of peroxisome-
proliferator-activated receptor (PPAR)-γ along the NF-κB
pathway [56].
The IP3 pathway has been a pharmacological target as
a treatment for diseases to regulate the immune response
and reduce inflammation [57–60]. This pathway could
represent a potential anti-inflammatory target to prevent
the persistent erythema and flushing episodes which are a
hallmark of rosacea.
The etiology of rosacea is unclear but may involve
genetic, immunological, and environmental factors. A role
for bacteria as contributory factors in the etiology of the
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condition has been suggested [2, 3, 24–26]. Bacteria resid-
ing within Demodex mites may stimulate neutrophil infil-
tration and activation once released from dead mites resid-
ing in the pilosebaceous unit. The results presented here
demonstrate how neutrophil activation and inflammation
may be induced by exposure to Bacillus-derived proteins.
Understanding the role and interaction of the various fac-
tors associated with the induction and persistence of rosa-
cea [6, 8] should allow the development of more targeted
therapies to reduce inflammation and ultimately cure this
disfiguring condition.
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